How many units of Survodutide should I draw?

It depends on your vial size, BAC water, and dose. For a 10mg vial with 2mL BAC water, a beginner dose of 600mcg is typically 12 units on a U-100 syringe. Use the calculator above for your exact numbers.

How much BAC water should I add to Survodutide?

The standard amount is 2mL of bacteriostatic water for a 10mg vial. More water gives a more dilute solution — easier to measure small doses. Less water means fewer injections per vial. Adjust the BAC water slider in the calculator to see how it changes your syringe units.

How long does a Survodutide vial last?

At a beginner dose of 600mcg weekly, a 10mg vial lasts about 16 doses. The calculator shows exact doses per vial for your selected tier.

What syringe should I use for Survodutide?

Most people use a U-100 insulin syringe (1mL / 100 units). For very small doses, a U-50 or U-30 syringe gives better precision. The calculator adjusts units automatically for whichever syringe you pick.

Survodutide Dosage Calculator

Weight LossInjectionPhase 3~6 days half-life

Survodutide is a dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim.

Up to 80% liver fat reductionDual-action weight loss mechanismLeading candidate for MASH/fatty liver treatmentSignificant body weight reduction

Vial Size

BAC Water (mL)

Dosing Level

600mcg · Weekly

Custom Dose (mcg) — optional

Syringe Type

12.0 units

100 units (1mL)

Concentration

5,000

mcg/mL

Draw Volume

0.120

Syringe Units

12.0

units

Doses / Vial

doses

Summary: Add 2mL BAC water to your 10mg vial. Draw to 12.0 units on a U-100 syringe for a 600mcg dose. This vial will last 16 doses.

Cycle Planner

Cycle Length (weeks)

Price Per Vial ($) — optional

Subcutaneous. Typical beginner frequency: weekly.

Survodutide Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = ~6 days

After 1 half-life (6d): 50% remainsAfter 2 half-lives (12d): 25% remainsAfter 3 half-lives (18d): 12.5% remains

At a 2.4mg dose: 50% = 1.2mg remaining after 6d. Recommended frequency: Weekly.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Survodutide Dosing Protocol

Level	Dose / Injection	Frequency
Beginner	600mcg	Weekly
Moderate	2,400mcg	Weekly
Aggressive	4,800mcg	Weekly

Note: Dual GLP-1/glucagon agonist by Boehringer Ingelheim. Up to 80% liver fat reduction in MASH trials. Titrate from 0.6mg weekly.

About Survodutide

Survodutide is a dual GLP-1/glucagon receptor agonist developed by Boehringer Ingelheim. What sets it apart is its remarkable effect on liver fat — clinical trials showed up to 80% reduction in liver fat content, making it a leading candidate for MASH (metabolic dysfunction-associated steatohepatitis). It also produces significant weight loss through combined appetite suppression and thermogenic fat burning.

View full Survodutideguide →Add to schedule →